Rosanna Marsella,
Professor
Department:
Small Animal Clinical Sciences
Business Phone:
(352) 392-2235
Business Email:
marsella@ufl.edu
Accomplishments
Superior Accomplishment Award
2006
·
University of Florida
Clinical Investigator Award
2002
·
Florida Association of Kennel Clubs
Best Resident Presentation
1996
·
American Academy of Veterinary Dermatology
Best Resident Presentation
1996
·
American College of Veterinary Dermatology
Best Resident Presentation, Phi Zeta Research Day
1996
·
University of Florida
Best Resident Seminar
1994-1995
·
University of Florida
Teaching Profile
Courses Taught
2010-2011,2017-2021
VEM5335 Equine Medicine
2017-2021
VEM5388 Sa Dermatology
2008-2023
VEM5869 Senior Clk Dermatol
2009-2023
VEM5387 Vet Dermatology
2018
GMS7980 Research for Doctoral Dissertation
2015-2016
VEM5171 Vet Pharmacology
2016
VEM5902 Supervised Teach Dev
2015
VME6934 Topics in Veterinary Medical Sciences
2010-2011,2013
VEM5115 Veterinary Histology
2006-2010
VEM5769 Core Clk Dermatology
2021
VME6905 Problems in Veterinary Medical Sciences
Board Certifications
-
DiplomateAmerican College of Veterinary Dermatology
Research Profile
Research Interests
– Immunology of allergic skin diseases
– Canine atopic dermatitis
– Pathogenesis and novel treatments
Publications
2022
Canine Epidermal Keratinocytes (CPEK) Grown in Monolayer Are Not Representative of Normal Canine Keratinocytes for Permeability Studies: Pilot Studies.
Veterinary sciences.
9(1)
[DOI] 10.3390/vetsci9010025.
[PMID] 35051109.
2022
Topical κ-opioid receptor agonist asimadoline improves dermatitis in a canine model of atopic dermatitis.
Experimental dermatology.
31(4):628-632
[DOI] 10.1111/exd.14507.
[PMID] 34839557.
2021
Advances in our understanding of canine atopic dermatitis.
Veterinary dermatology.
32(6):547-e151
[DOI] 10.1111/vde.12965.
[PMID] 33891338.
2021
Atopic Dermatitis in Domestic Animals: What Our Current Understanding Is and How This Applies to Clinical Practice.
Veterinary sciences.
8(7)
[DOI] 10.3390/vetsci8070124.
[PMID] 34357916.
2021
Investigation on the Effect of Dose, Frequency and Duration of Allergen Exposure on Development of Staphylococcal Infections in a Chronic Model of Canine Atopic Dermatitis.
Veterinary sciences.
9(1)
[DOI] 10.3390/vetsci9010008.
[PMID] 35051092.
2021
Reduced IL-31 receptor alpha splice variant mRNA following allergen challenge in a canine model of atopic dermatitis.
Allergy.
76(10):3206-3209
[DOI] 10.1111/all.15005.
[PMID] 34255350.
2020
Comparison of various treatment options for canine atopic dermatitis: a blinded, randomized, controlled study in a colony of research atopic beagle dogs.
Veterinary dermatology.
31(4):284-e69
[DOI] 10.1111/vde.12849.
[PMID] 32301565.
2020
Identification of differentially expressed microRNAs in the skin of experimentally sensitized naturally affected atopic beagles by next-generation sequencing.
Immunogenetics.
72(4):241-250
[DOI] 10.1007/s00251-020-01162-w.
[PMID] 32219493.
2020
Topical treatment with SPHINGOLIPIDS and GLYCOSAMINOGLYCANS for canine atopic dermatitis.
BMC veterinary research.
16(1)
[DOI] 10.1186/s12917-020-02306-6.
[PMID] 32197613.
2019
Double blinded, vehicle controlled, crossover study on the efficacy of a topical endocannabinoid membrane transporter inhibitor in atopic Beagles.
Archives of dermatological research.
311(10):795-800
[DOI] 10.1007/s00403-019-01963-4.
[PMID] 31446453.
2019
Update on pathogenesis, diagnosis, and treatment of atopic dermatitis in dogs.
Journal of the American Veterinary Medical Association.
254(11):1291-1300
[DOI] 10.2460/javma.254.11.1291.
[PMID] 31067173.
2018
A pilot study on the effect of oclacitinib on epicutaneous sensitization and transepidermal water loss in a colony of atopic beagle dogs.
Veterinary dermatology.
29(5):439-e146
[DOI] 10.1111/vde.12660.
[PMID] 29926994.
2018
Evaluation on the effects of 0.1% Peumus boldus leaf and Spiraea ulmaria plant extract combination on bacterial colonization in canine atopic dermatitis: A preliminary randomized, placebo controlled, double-blinded study.
Research in veterinary science.
118:164-170
[DOI] 10.1016/j.rvsc.2018.02.006.
[PMID] 29482177.
2018
Investigation of the correlation of serum IL-31 with severity of dermatitis in an experimental model of canine atopic dermatitis using beagle dogs.
Veterinary dermatology.
29(1):69-e28
[DOI] 10.1111/vde.12500.
[PMID] 28983982.
2018
Single blinded, randomized, placebo-controlled study on the effects of ciclosporin on cutaneous barrier function and immunological response in atopic beagles.
Veterinary immunology and immunopathology.
197:93-101
[DOI] 10.1016/j.vetimm.2018.02.001.
[PMID] 29475513.
2017
Atopic Dermatitis in Animals and People: An Update and Comparative Review.
Veterinary sciences.
4(3)
[DOI] 10.3390/vetsci4030037.
[PMID] 29056696.
2017
Effects of PAR2 antagonist on inflammatory signals and tight junction expression in protease-activated canine primary epithelial keratinocytes.
Experimental dermatology.
26(1):86-88
[DOI] 10.1111/exd.13121.
[PMID] 27306682.
2017
Evaluation of the in vitro effect of Boldo and Meadowsweet plant extracts on the expression of antimicrobial peptides and inflammatory markers in canine keratinocytes.
Research in veterinary science.
115:255-262
[DOI] 10.1016/j.rvsc.2017.05.021.
[PMID] 28549300.
2017
Increased filaggrin-metabolizing enzyme activity in atopic skin: a pilot study using a canine model of atopic dermatitis.
Veterinary dermatology.
28(5):479-e111
[DOI] 10.1111/vde.12443.
[PMID] 28393458.
2017
Randomized, double-blinded, placebo-controlled pilot study on the effects of topical blackcurrant emulsion enriched in essential fatty acids, ceramides and 18-beta glycyrrhetinic acid on clinical signs and skin barrier function in dogs with atopic dermatitis.
Veterinary dermatology.
28(6):577-e140
[DOI] 10.1111/vde.12467.
[PMID] 28736984.
2016
A comparative study of epidermal tight junction proteins in a dog model of atopic dermatitis.
Veterinary dermatology.
27(1):40-e11
[DOI] 10.1111/vde.12276.
[PMID] 26663564.
2016
Can ultraviolet light C decrease the environmental burden of antimicrobial-resistant and -sensitive bacteria on textiles?
Veterinary dermatology.
27(6):457-e121
[DOI] 10.1111/vde.12377.
[PMID] 27620856.
2016
Canine models of allergic skin disease.
Veterinary dermatology.
27(4):326-7
[DOI] 10.1111/vde.12311.
[PMID] 27273262.
2016
Decreased expression of caspase-14 in an experimental model of canine atopic dermatitis.
Veterinary journal (London, England : 1997).
209:201-3
[DOI] 10.1016/j.tvjl.2015.11.020.
[PMID] 26831171.
2016
Ticks associated with domestic dogs and cats in Florida, USA.
Experimental & applied acarology.
69(1):87-95
[DOI] 10.1007/s10493-016-0019-4.
[PMID] 26888081.
2016
Use of a Canine Model of Atopic Dermatitis to Investigate the Efficacy of a CCR4 Antagonist in Allergen-Induced Skin Inflammation in a Randomized Study.
The Journal of investigative dermatology.
136(3):665-671
[DOI] 10.1016/j.jid.2015.11.001.
[PMID] 26876716.
2015
Evaluation of antimicrobial peptides and cytokine production in primary keratinocyte cell culture from healthy and atopic beagles.
Experimental dermatology.
24(4):317-9
[DOI] 10.1111/exd.12660.
[PMID] 25660992.
2015
Experimental model for peanut allergy by epicutaneous sensitization in atopic beagle dogs.
Experimental dermatology.
24(9):711-2
[DOI] 10.1111/exd.12776.
[PMID] 26014917.
2015
First report in a dog model of atopic dermatitis: expression patterns of protease-activated receptor-2 and thymic stromal lymphopoietin.
Veterinary dermatology.
26(3):180-5, e36
[DOI] 10.1111/vde.12203.
[PMID] 25940870.
2015
Introduction to the review articles by ICADA on the pathogenesis of atopic dermatitis in dogs.
Veterinary dermatology.
26(2):77-8
[DOI] 10.1111/vde.12207.
[PMID] 25808534.
2015
Review: Clinical and histological manifestations of canine atopic dermatitis.
Veterinary dermatology.
26(2):79-e24
[DOI] 10.1111/vde.12196.
[PMID] 25676252.
2015
Review: Innate immunity, lipid metabolism and nutrition in canine atopic dermatitis.
Veterinary dermatology.
26(2):104-e28
[DOI] 10.1111/vde.12199.
[PMID] 25728538.
2015
Review: Lymphocytes, cytokines, chemokines and the T-helper 1-T-helper 2 balance in canine atopic dermatitis.
Veterinary dermatology.
26(2):124-e32
[DOI] 10.1111/vde.12205.
[PMID] 25808535.
2015
Review: Pathogenesis of canine atopic dermatitis: skin barrier and host-micro-organism interaction.
Veterinary dermatology.
26(2):84-e25
[DOI] 10.1111/vde.12197.
[PMID] 25683702.
2015
Review: Role of genetics and the environment in the pathogenesis of canine atopic dermatitis.
Veterinary dermatology.
26(2):95-e26
[DOI] 10.1111/vde.12198.
[PMID] 25703290.
2015
Review: The role of antibodies, autoantigens and food allergens in canine atopic dermatitis.
Veterinary dermatology.
26(2):115-e30
[DOI] 10.1111/vde.12201.
[PMID] 25728611.
2015
Tight junction proteins in the canine epidermis: a pilot study on their distribution in normal and in high IgE-producing canines.
Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.
79(1):46-51
[PMID] 25673908.
2014
A Prospective, Double-Lbinded, Controlled Pilot Study To Evaluate the Effects of Cyclosporine (Atopica) On Skin Barrier Function in Canine Atopic Dermatitis By Measurement of Trans-Epidermal Water Loss
International Journal of Applied Research in Veterinary Medicine.
12(1):18-23
2014
First case report of ultrastructural cutaneous abnormalities in equine atopic dermatitis.
Research in veterinary science.
97(2):382-5
[DOI] 10.1016/j.rvsc.2014.06.012.
[PMID] 25048836.
2013
Altered mRNA and protein expression of filaggrin in the skin of a canine animal model for atopic dermatitis.
Veterinary dermatology.
24(3):329-36, e73
[DOI] 10.1111/vde.12031.
[PMID] 23668858.
2013
Does filaggrin expression correlate with severity of clinical signs in dogs with atopic dermatitis?
Veterinary dermatology.
24(2):266-e59
[DOI] 10.1111/vde.12007.
[PMID] 23398596.
2013
Equine allergy therapy: update on the treatment of environmental, insect bite hypersensitivity, and food allergies.
The Veterinary clinics of North America. Equine practice.
29(3):551-7
[DOI] 10.1016/j.cveq.2013.08.006.
[PMID] 24267674.
2013
Fixing the skin barrier: past, present and future–man and dog compared.
Veterinary dermatology.
24(1):73-6.e17
[DOI] 10.1111/j.1365-3164.2012.01073.x.
[PMID] 23331682.
2013
Investigation of the effect of probiotic exposure on filaggrin expression in an experimental model of canine atopic dermatitis.
Veterinary dermatology.
24(2):260-e57
[DOI] 10.1111/vde.12006.
[PMID] 23432387.
2012
An update on the treatment of canine atopic dermatitis.
Veterinary medicine (Auckland, N.Z.).
3:85-91
[DOI] 10.2147/VMRR.S28488.
[PMID] 30101088.
2012
Are transepidermal water loss and clinical signs correlated in canine atopic dermatitis? A compilation of studies.
Veterinary dermatology.
23(3):238-e49
[DOI] 10.1111/j.1365-3164.2012.01055.x.
[PMID] 22575022.
2012
Current understanding of the pathophysiologic mechanisms of canine atopic dermatitis.
Journal of the American Veterinary Medical Association.
241(2):194-207
[DOI] 10.2460/javma.241.2.194.
[PMID] 22765366.
2012
Early exposure to probiotics in a canine model of atopic dermatitis has long-term clinical and immunological effects.
Veterinary immunology and immunopathology.
146(2):185-9
[DOI] 10.1016/j.vetimm.2012.02.013.
[PMID] 22436376.
2012
Transepidermal water loss in healthy and atopic dogs, treated and untreated: a comparative preliminary study.
Veterinary dermatology.
23(1):41-4, e9
[DOI] 10.1111/j.1365-3164.2011.01003.x.
[PMID] 21790811.
2011
Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.
Veterinary dermatology.
22(3):239-48
[DOI] 10.1111/j.1365-3164.2011.00967.x.
[PMID] 21414049.
2011
Expression and distribution of canine antimicrobial peptides in the skin of healthy and atopic beagles.
Veterinary immunology and immunopathology.
144(3-4):382-8
[DOI] 10.1016/j.vetimm.2011.08.004.
[PMID] 21889803.
2010
A randomized, double-blind, placebo-controlled study to evaluate the effect of EFF1001, an Actinidia arguta (hardy kiwi) preparation, on CADESI score and pruritus in dogs with mild to moderate atopic dermatitis.
Veterinary dermatology.
21(1):50-7
[DOI] 10.1111/j.1365-3164.2009.00773.x.
[PMID] 19843302.
2010
Canine atopic dermatitis: what’s new?
Compendium (Yardley, PA).
32(2):E1-4
[PMID] 20473848.
2010
Cutaneous periocular Habronema infection in a dromedary camel (Camelus dromedarius).
Veterinary dermatology.
21(5):527-30
[DOI] 10.1111/j.1365-3164.2009.00795.x.
[PMID] 20500499.
2010
Effects of age and allergen exposure on transepidermal water loss in a house dust mite-sensitized beagle model of atopic dermatitis.
Veterinary dermatology.
21(1):88-95
[DOI] 10.1111/j.1365-3164.2009.00839.x.
[PMID] 20187914.
2010
Environmental and oral challenge with storage mites in beagles experimentally sensitized to Dermatophagoides farinae.
Veterinary dermatology.
21(1):105-11
[DOI] 10.1111/j.1365-3164.2009.00859.x.
[PMID] 20187916.
2010
Investigation of the clinical efficacy of 0.2% topical stannous fluoride for the treatment of canine superficial pyoderma: a prospective, randomized, double-blinded, placebo-controlled trial.
Veterinary dermatology.
21(3):249-58
[DOI] 10.1111/j.1365-3164.2009.00785.x.
[PMID] 20230586.
2010
Safety and tolerability of 0.1% tacrolimus solution applied to the external ear canals of atopic beagle dogs without otitis.
Veterinary dermatology.
21(6):554-65
[DOI] 10.1111/j.1365-3164.2009.00786.x.
[PMID] 20609208.
2010
Tolerability and clinical efficacy of oral immunotherapy with house dust mites in a model of canine atopic dermatitis: a pilot study.
Veterinary dermatology.
21(6):566-71
[DOI] 10.1111/j.1365-3164.2010.00890.x.
[PMID] 20492623.
2010
Transmission electron microscopy studies in an experimental model of canine atopic dermatitis.
Veterinary dermatology.
21(1):81-8
[DOI] 10.1111/j.1365-3164.2009.00802.x.
[PMID] 20042040.
2009
Canine models of atopic dermatitis: a useful tool with untapped potential.
The Journal of investigative dermatology.
129(10):2351-7
[DOI] 10.1038/jid.2009.98.
[PMID] 19516261.
2009
Evaluation of Lactobacillus rhamnosus strain GG for the prevention of atopic dermatitis in dogs.
American journal of veterinary research.
70(6):735-40
[DOI] 10.2460/ajvr.70.6.735.
[PMID] 19496662.
2009
Immunohistochemical evaluation of filaggrin polyclonal antibody in atopic and normal beagles.
Veterinary dermatology.
20(5-6):547-54
[DOI] 10.1111/j.1365-3164.2009.00844.x.
[PMID] 20178493.
2009
Performance characteristics of a monoclonal antibody cocktail-based ELISA for detection of allergen-specific IgE in dogs and comparison with a high affinity IgE receptor-based ELISA.
Veterinary dermatology.
20(3):157-64
[DOI] 10.1111/j.1365-3164.2009.00740.x.
[PMID] 19374726.
2009
Temporal dynamic changes of phenotypic expression of peripheral CD4 cells during environmental allergen challenge in an experimental model of canine atopic dermatitis: a pilot study.
The Journal of veterinary medical science.
71(9):1177-81
[PMID] 19801897.
2009
Unravelling the skin barrier: a new paradigm for atopic dermatitis and house dust mites.
Veterinary dermatology.
20(5-6):533-40
[DOI] 10.1111/j.1365-3164.2009.00809.x.
[PMID] 20178491.
2008
Assessment of cross-reactivity among five species of house dust and storage mites.
Veterinary dermatology.
19(2):67-76
[DOI] 10.1111/j.1365-3164.2008.00654.x.
[PMID] 18336423.
2007
Allergen challenge decreases mRNA expression of regulatory cytokines in whole blood of high-IgE beagles.
Veterinary dermatology.
18(6):422-6
[PMID] 17991159.
2007
Evaluation of persistence of terbinafine in the hair of normal cats after 14 days of daily therapy.
Veterinary dermatology.
18(4):246-51
[PMID] 17610490.
2007
Investigation on the clinical efficacy and tolerability of a 0.4% topical stannous fluoride preparation (MedEquine Gel) for the treatment of bacterial skin infections in horses: a prospective, randomized, double-blinded, placebo-controlled clinical trial.
Veterinary dermatology.
18(6):444-50
[PMID] 17991163.
2007
The clinical and histopathological effects of prednisone on acute radiation-induced dermatitis in dogs: a placebo-controlled, randomized, double-blind, prospective clinical trial.
Veterinary dermatology.
18(4):217-26
[PMID] 17610486.
2007
Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis.
Veterinary dermatology.
18(2):78-86
[PMID] 17355421.
2006
Atopy: new targets and new therapies.
The Veterinary clinics of North America. Small animal practice.
36(1):161-74, vii
[PMID] 16364782.
2006
Cellular and cytokine kinetics after epicutaneous allergen challenge (atopy patch testing) with house dust mites in high-IgE beagles.
Veterinary dermatology.
17(2):111-20
[PMID] 16515653.
2006
Pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite after oral and intravenous administration of pentoxifylline to healthy adult horses.
American journal of veterinary research.
67(9):1621-7
[PMID] 16948611.
2006
Pilot investigation of a model for canine atopic dermatitis: environmental house dust mite challenge of high-IgE-producing beagles, mite hypersensitive dogs with atopic dermatitis and normal dogs.
Veterinary dermatology.
17(1):24-35
[PMID] 16412117.
2006
Studies on the role of routes of allergen exposure in high IgE-producing beagle dogs sensitized to house dust mites.
Veterinary dermatology.
17(5):306-12
[PMID] 16961815.
2005
Atopy patch test reactions in high-IgE beagles to different sources and concentrations of house dust mites.
Veterinary dermatology.
16(5):308-14
[PMID] 16238810.
2005
Calcineurin inhibitors: a novel approach to canine atopic dermatitis.
Journal of the American Animal Hospital Association.
41(2):92-7
[PMID] 15767651.
2005
Comparison of the clinical efficacy of oral terbinafine and ketoconazole combined with cephalexin in the treatment of Malassezia dermatitis in dogs–a pilot study.
Veterinary dermatology.
16(3):171-6
[PMID] 15960630.
2004
Evaluation of adrenal function in small-breed dogs receiving otic glucocorticoids.
Veterinary dermatology.
15(6):363-8
[PMID] 15585011.
2004
Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study.
Veterinary dermatology.
15(5):294-303
[PMID] 15500481.
2004
Investigation on the effects of topical therapy with 0.1% tacrolimus ointment (Protopic) on intradermal skin test reactivity in atopic dogs.
Veterinary dermatology.
15(4):218-24
[PMID] 15305928.
2003
Animal models of atopic dermatitis.
Clinics in dermatology.
21(2):122-33
[PMID] 12706330.
2003
Comparison of serum dexamethasone concentrations in cats after oral or transdermal administration using pluronic lecithin organogel (PLO): a pilot study.
Veterinary dermatology.
14(2):83-9
[PMID] 12662265.
2002
Investigation on the use of 0.3% tacrolimus lotion for canine atopic dermatitis: a pilot study.
Veterinary dermatology.
13(4):203-10
[PMID] 12174182.
2002
PCR-based detection of Pythium and Lagendium DNA in frozen and ethanol-fixed animal tissues.
Veterinary dermatology.
13(4):187-94
[PMID] 12229858.
2002
The effects of capsaicin topical therapy in dogs with atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over clinical trial.
Veterinary dermatology.
13(3):131-9
[PMID] 12074702.
2001
Double-blinded, placebo-controlled, cross-over pilot study on the efficacy of zileuton for canine atopic dermatitis.
Veterinary dermatology.
12(4):189-95
[PMID] 11493402.
2001
Intradermal skin test reactivity to histamine and substance P is blunted in dogs with atopic dermatitis.
Veterinary dermatology.
12(3):149-54
[PMID] 11420930.
2001
Sulphido-leukotriene production from peripheral leukocytes and skin in clinically normal dogs and house dust mite positive atopic dogs.
Veterinary dermatology.
12(1):3-12
[PMID] 11301537.
2001
The ACVD task force on canine atopic dermatitis (VII): mediators of cutaneous inflammation.
Veterinary immunology and immunopathology.
81(3-4):205-13
[PMID] 11553381.
2001
The ACVD task force on canine atopic dermatitis (XIII): threshold phenomenon and summation of effects.
Veterinary immunology and immunopathology.
81(3-4):251-4
[PMID] 11553387.
2001
The ACVD task force on canine atopic dermatitis (XXII): nonsteroidal anti-inflammatory pharmacotherapy.
Veterinary immunology and immunopathology.
81(3-4):331-45
[PMID] 11553396.
2001
Update on the role of leukotrienes in the pathogenesis of atopy: a comparative review.
Veterinary dermatology.
12(2):63-74
[PMID] 11360339.
2000
A Scoring Index for Clinical Signs of Flea Allergy Dermatitis in the cat.
Veterinary therapeutics : research in applied veterinary medicine.
1(4):213-9
[PMID] 19757567.
2000
Double-blind, placebo-controlled study to evaluate two miconazole conditioners for the treatment of Malassezia dermatitis in dogs.
Veterinary therapeutics : research in applied veterinary medicine.
1(3):141-9
[PMID] 19757576.
2000
Pharmacokinetics of pentoxifylline in dogs after oral and intravenous administration.
American journal of veterinary research.
61(6):631-7
[PMID] 10850837.
1999
Advances in flea control.
The Veterinary clinics of North America. Small animal practice.
29(6):1407-24
[PMID] 10563008.
1997
Double-blind pilot study on the effects of ketoconazole on intradermal skin test and leukotriene C4 concentration in the skin of atopic dogs.
Veterinary dermatology.
8(1):3-10
[DOI] 10.1111/j.1365-3164.1997.tb00257.x.
[PMID] 34645031.
1997
Use of pentoxifylline in the treatment of allergic contact reactions to plants of the Commelinceae family in dogs.
Veterinary dermatology.
8(2):121-126
[DOI] 10.1046/j.1365-3164.1997.d01-6.x.
[PMID] 34645064.
Grants
Feb 2022
ACTIVE
Development of a biologic against equine IL-31
Role: Principal Investigator
Funding: AMER COL OF VET DERMATOLOGY
Jun 2021
ACTIVE
The effect of probiotic vs. placebo on the clinical response and cytokine profile in felines with allergic dermatitis: a randomized, double blinded controlled study.
Role: Other
Funding: NESTLE PURINA PETCARE COMPANY
Aug 2020
– Sep 2021
Effect of supplement on skin lipid concentration in healthy dogs
Role: Principal Investigator
Funding: NUTRAMAX LABORATORIES VETERINARY SCIENCE
Jul 2020
– Jun 2021
Topical bacteriophage therapy for staphylococcal superficial pyoderma in horses: a proof of concept study
Role: Other
Funding: AMER COL OF VET DERMATOLOGY
Jun 2020
ACTIVE
Topical bacteriophage therapy for staphylococcal superficial pyoderma in horses: a pilot study
Role: Principal Investigator
Funding: AUS AND NZL COLLEGE OF VET SCIENTISTS
May 2020
– Apr 2021
The Development of a Protocol for Evaluating Probiotic Treatment of Canine Atopic Dermatitis
Role: Principal Investigator
Funding: ARCHER DANIELS MIDLAND COMPANY
Nov 2019
– Oct 2020
Investigation of the role of IL-33 on atopic dermatitis
Role: Principal Investigator
Funding: SCOUT BIO
May 2019
– Apr 2020
Investigation of OKV-1001, an extended release mycophenolic acid, in a canine model of atopic dermatitis.
Role: Principal Investigator
Funding: OKAVA PHARMACEUTICALS
Feb 2019
– Aug 2021
Genetics analysis of an established colony of laboratory beagles with atopic dermatitis
Role: Principal Investigator
Funding: AMER COL OF VET DERMATOLOGY
Sep 2018
– Feb 2020
Oclacitinib and its role on dendritic cell cytokine release in atopic and normal dogs, in vitro, a pilot study
Role: Principal Investigator
Funding: AMER COL OF VET DERMATOLOGY
Aug 2018
– Aug 2020
Determination of effects of topical WOL071-308 in a colony of atopic Beagles
Role: Principal Investigator
Funding: DR AUGUST WOLFF GmbH & CO KG ARZNEIMITTE
Feb 2017
– Mar 2018
Pilot study to evaluate the clinical efficacy of Donepezil to decrease signs of atopic dermatitis in an experimental model using high IgE producing Beagles
Role: Principal Investigator
Funding: NEURODERMA
Aug 2016
– Jun 2018
Pilot Study using microencapsulated Diindolylmethane (DIM) to modulate the inflammatory response in a canine model of atopic dermatitis
Role: Principal Investigator
Funding: BIORESPONSE LLC
Aug 2016
– Aug 2017
PILOT STUDY TO EVALUATE THE EFFECTS OF AN ORAL SUPPLEMENT ON SKIN BARRIER FUNCTION
Role: Principal Investigator
Funding: BIOIBERICA S A
Apr 2016
– Mar 2018
PILOT INVESTIGATIONS ON THE EFFECTS OF A JAK1/2 INHIBITOR ONSKIN BARRIER FUNCTION
Role: Principal Investigator
Funding: UF FOUNDATION
Mar 2016
– Mar 2017
Determination of Effects of WOL067-531, a Modulator of the Endocannabinoid System, in a Canine Animal Model of Atopic Dermatitis Beagles
Role: Principal Investigator
Funding: DR AUGUST WOLFF GmbH & CO KG ARZNEIMITTE
Jan 2016
– Jan 2017
August Wolff Consulting Agreement
Role: Principal Investigator
Funding: DR AUGUST WOLFF GmbH & CO KG ARZNEIMITTE
Sep 2015
– Jun 2016
A study to evaluate the clinical efficacy of SAR346923B
Role: Principal Investigator
Funding: MERIAL (USA)
Aug 2015
– Aug 2016
Pilot Study to Evaluate The Effects of a Topical Formulation Alone or in Combination with an Oral Supplement on Skin Barrier Function and Clinical Signs in Dogs With Atopic Dermatitis
Role: Principal Investigator
Funding: BIOIBERICA S A
Jun 2015
– Jun 2018
Clinical evaluation of DP955 to treat canine otitis
Role: Principal Investigator
Funding: DECHRA PHARMACEUTICALS
Dec 2014
– Apr 2016
In Vitro Efficacy of an H4R Antagonist to Affect Cytokines Involved in Atopic Dermatitis
Role: Principal Investigator
Funding: MERIAL (USA)
Feb 2014
– Feb 2016
House dust mites and canine atopic dermatitis: effects on toll like receptors, NF-+?B/STAT3, and the inflammasome complex
Role: Principal Investigator
Funding: AMER COL OF VET DERMATOLOGY
Education
Diplomate
1996
·
American College of Veterinary Dermatology
DVM, Veterinary Medicine (Summa cum Laude)
1991
·
Universita’ degli Studi Di Milano
Contact Details
Phones:
- Business:
- (352) 392-2235
Emails:
- Business:
- marsella@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100126
GAINESVILLE FL 32610 - Business Street:
-
2015 SW 16TH AVE
GAINESVILLE FL 32608